
Biotech Risk and Metals Rotation: Reading the August 10 Charts
Sam Gatlin opened with a biotech loss, then worked through metals, healthcare and breakout candidates. The episode kept position size and price confirmation in the same conversation.
IDEAS / Tickers
Vertex Pharmaceuticals

Sam Gatlin opened with a biotech loss, then worked through metals, healthcare and breakout candidates. The episode kept position size and price confirmation in the same conversation.

Homebuilders filled the screen on December 15, 2023. A less conspicuous group had been turning up for weeks: specialty insurers that kept making highs without much volatility.